Diabetic Kidney Disease (DKD) Comprehensive Management — free guideline decision tool
This tool frames multi-pillar management of diabetic kidney disease by eGFR and albuminuria, spanning RAAS inhibition, SGLT2 inhibitors, finerenone, glucose-lowering, and blood pressure, per KDIGO 2022.
Open guideline tool →Guideline-based
Implements the decision logic from published clinical guidelines.
Runs in your browser
No installation. Enter the patient's values and get a guideline recommendation instantly.
Data stays local
Nothing is uploaded. Results are for licensed clinicians only.
Common questions
What does Diabetic Kidney Disease (DKD) Comprehensive Management do?
Use to assemble the DKD regimen: RAAS blockade for albuminuria/hypertension, an SGLT2i at eGFR ≥ 20, finerenone for residual albuminuria, and statin/BP/lifestyle for all patients.
How is the result calculated?
Pillars by eGFR/albuminuria: ACEi/ARB (albuminuria), SGLT2i (eGFR ≥ 20), finerenone (eGFR ≥ 25 + UACR ≥ 30 + normal K on RASi ± SGLT2i), metformin (eGFR ≥ 30) → GLP-1 RA, statin + BP < 130/80 for all.
Is this a substitute for clinical judgement?
No. All results are decision-support only, for licensed clinicians. They must be individualized to the whole patient and the latest guideline version.
Run Diabetic Kidney Disease (DKD) Comprehensive Management now
This tool frames multi-pillar management of diabetic kidney disease by eGFR and albuminuria, spanning RAAS inhibition, SGLT2 inhibitors, finerenone, glucose-lowering, and blood pressure, per KDIGO 2022.
Open guideline tool →For licensed clinicians. Not a substitute for clinical judgement.